Literature DB >> 17822788

YB-1 binds to the MMP-13 promoter sequence and represses MMP-13 transactivation via the AP-1 site.

Shaija Samuel1, Katherine K Beifuss, Lori R Bernstein.   

Abstract

Matrix metalloproteinases (MMPs) are key enzymes that implement degradation of the extracellular matrix during cellular invasion in development, tissue remodeling, and pathogenic disease states. MMP-13 has pivotal roles in the pathogenesis of invasive cancers and arthritis. Here we report the identification of Y-box binding protein-1 (YB-1) as a new repressor of MMP-13 transactivation. YB-1 binds in vitro in DNA affinity chromatography to the activator protein-1 (AP-1) DNA sequence within the MMP-13 promoter. Chromatin immunoprecipitation assays reveal that YB-1 binds in living cells to the MMP-13 gene promoter to a region of the MMP-13 promoter containing the AP-1 site. YB-1 represses tumor promoter-induced MMP-13 promoter transactivation at the AP-1 site. This is the first report demonstrating YB-1 binding in vitro and in living cells to a mammalian AP-1 target gene, and the first report of YB-1 regulation of the MMP-13 promoter.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17822788      PMCID: PMC2043501          DOI: 10.1016/j.bbaexp.2007.07.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  44 in total

1.  Control of renin synthesis.

Authors:  Pontus B Persson; Angela Skalweit; Ralf Mrowka; Bernd-Joachim Thiele
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-09       Impact factor: 3.619

2.  Identification of constitutive phosphorylation sites on the Epstein-Barr virus ZEBRA protein.

Authors:  Ayman S El-Guindy; So Yeon Paek; Jill Countryman; George Miller
Journal:  J Biol Chem       Date:  2005-12-01       Impact factor: 5.157

Review 3.  AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration.

Authors:  T Herdegen; V Waetzig
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

Review 4.  Jun, the oncoprotein.

Authors:  P K Vogt
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

5.  The transcriptional regulatory protein, YB-1, promotes single-stranded regions in the DRA promoter.

Authors:  G H MacDonald; Y Itoh-Lindstrom; J P Ting
Journal:  J Biol Chem       Date:  1995-02-24       Impact factor: 5.157

6.  Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation.

Authors:  C Y Chen; R Gherzi; J S Andersen; G Gaietta; K Jürchott; H D Royer; M Mann; M Karin
Journal:  Genes Dev       Date:  2000-05-15       Impact factor: 11.361

Review 7.  Diverse roles of macrophage matrix metalloproteinases in tissue destruction and tumor growth.

Authors:  S D Shapiro
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

Review 8.  Regulation of matrix metalloproteinase gene expression.

Authors:  Chunhong Yan; Douglas D Boyd
Journal:  J Cell Physiol       Date:  2007-04       Impact factor: 6.384

9.  Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation.

Authors:  Andreas G Bader; Peter K Vogt
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

10.  Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer.

Authors:  C Gessner; C Woischwill; A Schumacher; U Liebers; H Kuhn; P Stiehl; K Jürchott; H D Royer; C Witt; G Wolff
Journal:  Eur Respir J       Date:  2004-01       Impact factor: 16.671

View more
  9 in total

1.  Sumoylation and nuclear translocation of S100A4 regulate IL-1beta-mediated production of matrix metalloproteinase-13.

Authors:  Keally J Miranda; Richard F Loeser; Raghunatha R Yammani
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

2.  Species-specific sensitivity to TGFβ signaling and changes to the Mmp13 promoter underlie avian jaw development and evolution.

Authors:  Spenser S Smith; Daniel Chu; Tiange Qu; Jessye A Aggleton; Richard A Schneider
Journal:  Elife       Date:  2022-06-06       Impact factor: 8.713

Review 3.  JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process?

Authors:  Tatiana R Coelho; Luis Almeida; Pedro A Lazo
Journal:  Virol J       Date:  2010-02-18       Impact factor: 4.099

4.  ANKRD1 acts as a transcriptional repressor of MMP13 via the AP-1 site.

Authors:  Karinna Almodóvar-García; Minjae Kwon; Susan E Samaras; Jeffrey M Davidson
Journal:  Mol Cell Biol       Date:  2014-02-10       Impact factor: 4.272

5.  Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition.

Authors:  Bow J Tauro; Rommel A Mathias; David W Greening; Shashi K Gopal; Hong Ji; Eugene A Kapp; Bradley M Coleman; Andrew F Hill; Ulrike Kusebauch; Janice L Hallows; David Shteynberg; Robert L Moritz; Hong-Jian Zhu; Richard J Simpson
Journal:  Mol Cell Proteomics       Date:  2013-05-03       Impact factor: 5.911

6.  RNA binding proteins regulate anabolic and catabolic gene expression in chondrocytes.

Authors:  B T McDermott; S Ellis; G Bou-Gharios; P D Clegg; S R Tew
Journal:  Osteoarthritis Cartilage       Date:  2016-02-04       Impact factor: 6.576

7.  Effect of shRNA Mediated Silencing of YB-1 Protein on the Expression of Matrix Collagenases in Malignant Melanoma Cell In Vitro.

Authors:  Wisam Nabeel Ibrahim; Abd Almonem Doolaanea; Mohammad Syaiful Bahari Bin Abdull Rasad
Journal:  Cells       Date:  2018-01-10       Impact factor: 6.600

8.  Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma.

Authors:  Suriya Narayanan Murugesan; Birendra Singh Yadav; Pramod Kumar Maurya; Amit Chaudhary; Swati Singh; Ashutosh Mani
Journal:  J Genomics       Date:  2018-06-26

9.  Overexpression of YB1 C-terminal domain inhibits proliferation, angiogenesis and tumorigenicity in a SK-BR-3 breast cancer xenograft mouse model.

Authors:  Jian-Hong Shi; Nai-Peng Cui; Shuo Wang; Ming-Zhi Zhao; Bing Wang; Ya-Nan Wang; Bao-Ping Chen
Journal:  FEBS Open Bio       Date:  2016-01-11       Impact factor: 2.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.